Terumo Medical history

Such was the case in 1973, when the company began manufacturing and distributing its own line of catheters and urine bags.

The scene is the opening ceremony for new factory of Kimball Terumo Corporation (currently known as Terumo Medical Corporation) in April 1974 in the city of Elkton, Maryland.

In 1977, the company released its first generation of hollow fiber dialyzers, a product that enabled it to enter the market for the manufacturing of artificial organs.

The company continued to develop its soft bag delivery business, and in 1980 released the first soft-bag nutrient solutions line for the Japanese market.

1982: The first hollow-fiber oxygenator is launched.

In 1983, the company released a "predictive" digital clinical thermometer.

1984 Cardiovascular Devices Inc. (CDI) introduced the Gas Stat System, the industry’s first continuous monitor

Then, in 1985, Terumo entered a new product category, unveiling the first of its diagnostic and surgical intervention catheter products, the Radifocus guidewire for angiography.

In 1988, the company released two such home medical products, an automated peritoneal dialysis system and a digital blood-pressure monitor.

In 1995, Terumo opened its first Chinese subsidiary, in Hangzhou City, which took over manufacturing of a number of Terumo's products for the Japanese market.

Meanwhile, in 1997, Terumo launched a new subsidiary and manufacturing facility in the United Kingdom which began production of blood lines for the company's oxygenator products.

That same year, Terumo's European operations were boosted with new technology, leading to the creation in Belgium of both a new facility for production of the Radifocus catheter systems range and, in 1998, the launch of production capacity for the company's sterile tubing products.

Since 1999, Terumo Cardiovascular has expanded its cardiac surgery product line to include vascular grafts, endoscopic vessel harvesting, and more.

In 2000, Terumo opened its newest production facility, in the Philippines, in order to produce syringes and other products to meet the surge in demand in the southeast Asian market.

Pharmaceutical products account for 23 percent and the largest share of Terumo's sales, which topped ¥176 billion ($1.39 billion) in 2001.

Terumo continued to take steps to increase its position in the worldwide market, including the establishment in May 2002 of a dedicated sales and marketing subsidiary for its South and Central American operations.

2005 Terumo Corporation became number one in the global perfusion products market and began to expand its portfolio to new product categories in the cardiac operating room VirtuoSaph™ Endoscopic Vein Harvesting System launched

2007 Terumo Cardiovascular Systems became the exclusive distributor of Vascutek® Vascular Grafts in the United States

2008 CAPIOX® FX Oxygenator, the industry’s first oxygenator with an integrated arterial filter, introduced CAPIOX® FX05 Oxygenator, the industry’s first pediatric oxygenator with an integrated arterial filter, launched

2011 Terumo Corporation acquired Harvest Technologies Corporation, a leader in the development of point-of-care cell therapy

2013 Terumo Cardiovascular Group formed, creating a global headquarters focused on the needs of cardiac surgery teams worldwide.

2014 Terumo Cardiovascular Group became the exclusive distributor of Nonin Medical’s SenSmart™ Model X-100 in the United States

2016 CAPIOX® FX Advance Oxygenator introduced, further reducing prime volume and lowering hemodilution.

2019 Capiox® NX19 Oxygenator with UltraPrime™ Technology introduced, Terumo’s smallest full-size adult oxygenator to date.

2020 Terumo Cardiovascular Group updates name to Terumo Cardiovascular and introduces new logo, to focus on its market and customers.